Analysis of Factors Affecting the Quality of Life of Breast Cancer Patients Undergoing Chemotherapy at RSUD Gunung Jati Cirebon in 2024

Main Article Content

Lita Gustiarahma
Universitas Swadaya Gunung Jati, Indonesia
Moch. Yusuf Handoyo
Universitas Swadaya Gunung Jati, Indonesia
Witri Pratiwi
Universitas Swadaya Gunung Jati, Indonesia

Breast cancer was the leading cause of cancer-related deaths among women worldwide in 2020 and 2022, particularly in Indonesia. This disease is considered terrifying for many women because of its life-threatening nature, which can cause disruptions in various aspects of life. This means that breast cancer patients are vulnerable to a decreased quality of life. The importance of conducting routine assessments of quality of life lies in identifying and providing early interventions for patients at high risk of deterioration. This study aims to determine the factors that affect the quality of life of breast cancer patients. This research is a cross-sectional study involving breast cancer patients undergoing chemotherapy at RSUD Gunung Jati Cirebon during the period of June to July 2024. Data were collected through patient interviews and medical record reviews. Quality of life (QoL) was assessed using the Indonesian version of the EORTC QLQ-C30 questionnaire. Differences were found in the mean scores across various groups of variables. The results of statistical tests showed significant associations between age (p < 0.001), income (p < 0.001), cancer stage (p < 0.001), nutritional status (p = 0.045), and anxiety (p < 0.001) with the quality of life of breast cancer patients. Meanwhile, duration of illness (p = 0.073) and type of treatment (p = 0.359) had no significant effect on QoL. In summary, age, income, cancer stage, nutritional status, and anxiety were the factors that influenced the QoL of breast cancer patients undergoing chemotherapy.


Keywords: Breast cancer, chemotherapy, EORTC QLQ C-30, quality of life
Ardiani, H., Lismayanti, L., & Rosnawaty, R. (2019). Faktor-faktor yang Berpengaruh terhadap Kualitas Hidup Lansia di Kelurahan Mugarsari Kecamatan Tamansari Kota Tasikmalaya Tahun 2014. Healthcare Nursing Journal, 1(1), 42–50. http://www.depkes.go.id
Asia, S. E. (2024). South-eastern asia. 9–10. https://doi.org/10.1002/ijc.33588
Aslam, M. S., Naveed, S., Ahmed, A., Abbas, Z., Gull, I., & Athar, M. A. (2014). Side Effects of Chemotherapy in Cancer Patients and Evaluation of Patients Opinion about Starvation Based Differential Chemotherapy. Journal of Cancer Therapy, 5(8), 817–822. https://doi.org/10.4236/jct.2014.58089
Biparva, A. J., Raoofi, S., Rafiei, S., Kan, F. P., Kazerooni, M., Bagheribayati, F., Masoumi, M., Doustmehraban, M., Sanaei, M., & Zarabi, F. (2022). Global quality of life in breast cancer: systematic review and meta-analysis. BMJ Supportive & Palliative Care, 13(e3), e528–e536.
Bozzette, S. A. (2011). HIV and cardiovascular disease. Clinical Infectious Diseases, 53, 92–93. https://doi.org/10.1093/cid/cir275
Costa, W. A., Monteiro, M. N., Queiroz, J. F., & Gonçalves, A. K. (2017). Pain and quality of life in breast cancer patients. Clinics, 72(12), 758–763.
Ferlay, J., Rebecca, M. E., & Mph, L. S. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 229–263. https://doi.org/10.3322/caac.21834
Gita, S., Jain, D. P. M. B., & Sharma, D. K. K. (2023). Quality of life of breast cancer patients. International Midwifery and Nursing Practice, 6(1), 22–24. https://doi.org/10.33545/26630427.2023.v6.i1a.130
Hero, S. K. (2020). Faktor Resiko Kanker Payudara. J Bagus, 2(1), 402–406.
International, W. C. R. F. (2022). Breast Cancer Statistics. https://www.wcrf.org/cancer-trends/breast-cancer-statistics/
Jones, H. E., Calixte, C., Manze, M., Perlman, M., Rubin, S., Roberts, L., & Romeo, D. (2020). Primary care patients’ preferences for reproductive health services needs assessment and service availability in New York Federally Qualified Health Center. Contraception, 101(4), 226–230. https://doi.org/10.1016/j.contraception.2019.12.003
Lenz-Alcayaga, R., Paredes-Fernández, D., Verdejo, F. G., Páez-Pizarro, L., & Hernández-Sánchez, K. (2025). Economic evaluation: Impact on costs, time, and productivity of the incorporation of integrative digital pathology (IDP) in the anatomopathological analysis of breast cancer in a national reference public provider in Chile. Journal of Pathology Informatics, 16, 100417. https://doi.org/https://doi.org/10.1016/j.jpi.2024.100417
Lewandowska, A., Rudzki, G., & Lewandowski, T. (2020). Quality of life of cancer patients treated with chemotherapy. International Journal of Environmental Research and Public Health, 17(19). https://doi.org/10.3390/ijerph17196938
Liambo, I. S., Frisitiohady, A., & Malaka, M. H. (2022). Review: Patofisiologi, Epidemiologi, dan Lini Sel Kanker Payudara. Pharmauho Jurnal Farmasi Sains Dan Kesehatan, 8(1), 17–22. https://doi.org/10.33772/pharmauho.v8i
Mokhtari-Hessari, P., & Montazeri, A. (2020). Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health and Quality of Life Outcomes, 18(1), 338.
Organization, W. H. (2020). Global Cancer Observatory, Indonesia Fact Sheet. https://www.who.int/publications/m/item/cancer-idn-2020
Organization, W. H. (2022). Global Cancer Observatory, Indonesia Fact Sheet. https://gco.iarc.who.int/media/globocan/factsheets/populations/360-indonesia-fact-sheet.pdf
Paraskevi, T. (2012). Quality of life outcomes in patients with breast cancer. Oncology Reviews, 6(1), e2–e2.
Paris, D. H., & White, N. J. (2011). South-Eastern Asia. In Infectious Diseases: A Geographic Guide (pp. 170–187). https://doi.org/10.1002/9781119971641.ch13
Shurtleff, D., & Lawrence, D. (2012). HIV and substance abuse: a commentary. Current HIV Research, 10(2). https://doi.org/10.2174/157016212802138760
Wamai, R. G., Morris, B. J., & Bailis, S. A. (2011). Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. Journal of the International AIDS Society, 14, 49. https://doi.org/10.1186/1758-2652-14-49
Wang, Y. L., Wu, D., Nguyen-Huynh, M. N., Zhou, Y., Wang, C. X., Zhao, X. Q., Liao, X. L., Liu, L. P., Wang, Y. J., & Investigators, Pr. S. (2010). Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: A consecutive cross-sectional survey. Clinical and Experimental Pharmacology and Physiology, 37(8), 775–781.